04.24.25 -- The Risks Of AI In Clinical Research From A Trial Management Perspective

Strategic Key Opinion Leaders (KOLs) engagement is crucial for accelerating innovation in trials, however, identifying the right experts is challenging due to fragmented data and evolving expertise.

Dr. Jie Shen, Research Fellow and Director of Digital Science at AbbVie, shares lessons learned from incorporating digital measures of physical activity into Phase 3 immunology clinical trials.

Join the Co-CEO of CRIO, as he explores research site challenges and how site-based technologies can reduce administrative burdens, enhance efficiency, and eliminate redundant one-time-use technologies.

Whether you're a sponsor, site, or technology vendor, now is the time to embrace One Home and join this industry-wide collaboration.

The Bring Your Own Device (BYOD) model, supported by Trialkit, is an innovative approach in clinical trials that allows participants to use personal smartphones or tablets for data collection.

Now more than ever, stakeholders need harmony among their disparate systems — and that starts with the right organizational mindset: a culture of connectivity. Here’s what our experts recommend.